Milestone Pharmaceuticals Inc. (MIST) has a consensus analyst rating of Buy, based on 7 analysts covering the stock. Of those, 6 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for MIST is $8.00, representing a +294.1% upside from the current price of $2.03. Price targets range from a low of $8.00 to a high of $8.00.
